Back to Top

Information For Authors

Submitting Your Manuscript

ORCID IDs

The submitting author is required to complete the submission using an ORCID identifier. Please visit the ORCID website for more information, or to register.  You must have an account in ScholarOne for DNA and Cell Biology before logging in with an ORCID identifier.

Manuscript Submission Site

Create an Account in ScholarOne

If you do not already have an account in ScholarOne for DNA and Cell Biology, you will need to create one.  Once you create your account, you may log in to the system to begin your submission.  Each listed author on a submission must either have an account, or have one created, in the submission system.

CLICK HERE TO SUBMIT YOUR MANUSCRIPT

See JOURNAL STANDARDS AND BEST PRACTICES STATEMENT

Check the Journal’s PEER REVIEW POLICIES

Manuscript Preparation
Determining Authorship

(See AUTHORSHIP DEFINITION AND RESPONSIBILITIES)

All authors, including the co-authors, should be responsible for a significant part of the manuscript. All authors and co-authors should have taken part in writing the manuscript, reviewing it, and revising its intellectual and technical content. Any author whose name appears on a manuscript assumes responsibility and accountability for the results.

Submission Process

CLICK HERE FOR ARTICLE TYPES AND WORD LIMITS

All Original submissions must contain:

  • An Institutional Review Board (IRB) approval (or waiver) statement in the Methods section
  • Acknowledgments section (if applicable) after the Conclusion of the manuscript, followed by
  • An Author Contribution statement for each listed author (list contributors' first and last names in this section; do not use initials), followed by
  • An Author Disclosure Statement for each author listed on a submission, even if there are no conflicts to disclose, followed by,
  • Funding statement(s), even if there is no funding information to declare.

See IRB APPROVALS, PATIENT CONSENT, & ETHICAL TREATMENT OF ANIMALS

See AUTHOR CONFIRMATION AND DISCLOSURE STATEMENTS

See FUNDING INFORMATION: COMPLIANCE AND STATEMENTS

All manuscripts must be prepared in accordance with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals.  

When submitting your manuscript for peer review, be prepared to:

  • Provide a cover letter
  • Enter the full title of the manuscript
  • Enter the full names and institutional affiliations of ALL listed authors
  • Enter ALL listed authors' institutional email addresses
  • Identify the corresponding author
  • Enter a running (abbreviated) title of no more than 50 characters (including spaces).
  • Enter 3–6 keywords or phrases to assist in the selection of skilled reviewers in the field for the purposes of peer review.
  • Provide an unstructured abstract of no more than 200 words, stating the aims, results, and conclusions drawn from the study.
  • Provide the names and email addresses of at least five potential preferred reviewers familiar with the field.  Please make sure that preferred reviewers are not from your university or institution or with whom you have collaborated. Only suggested reviewers who have an academic and/or institutional email address will be considered.  Email addresses with generic domain names (Gmail, Hotmail, Yahoo, AOL, etc.) will be disregarded. Anyone whom the author does not want to be considered should also be named as a non-preferred reviewer. Ultimate reviewer selection is at the Editor’s discretion.
  • Confirm that the material has not been published or submitted for publication elsewhere.

Create an Effective Title

  • Manuscript titles should be brief, contain key terms, and clearly identify the purpose of the work conducted
  • Manuscript titles should not exceed 15 -18 words. Exceptions can be made with the Editor’s approval
  • Manuscript titles should be direct and to the point. Remember that the journal has a global readership, so clear and concise non-vernacular language is most effective
  • Avoid the use of specific locations in the title
  • Do not use proprietary/trademarked names in the title
  • Do not use acronyms in the title unless they are universally recognized and accepted
  • NOTE: The title page of your submission must be included as part of your main text document (not as a separate file).

File Naming

All file names should be in English and contain only alphanumeric characters.  Do not include spaces, symbols, special characters, dashes, dots, or underscores.  Label each file with the first author's last name, followed by the content of the file (i.e.: SmithText; SmithTables; SmithFigureLegends; SmithFig1, etc.)

Important:  Please upload individual files of all manuscript material as described herein — please do NOT upload a combined PDF file containing all material in your submission.  

Preparation of Manuscript

Prepare text of manuscripts, figure legends, and tables in Microsoft Word, double spaced. The order of elements in each manuscript should be:

  • Title page (with full manuscript title, all contributing authors and their affiliations, a short running title, a denotation of the corresponding author, and a list of 3-6 keywords)
  • Abstract
  • Main text (do not embed figures or tables)
  • Conclusion (as a separate paragraph, not as part of the Discussion section)
  • Acknowledgments (if applicable)
  • Authorship confirmation statement (see below)
  • Author(s’) disclosure statement(s) (see below)
  • Funding statement (see below)
  • References
  • Figure legends
  • Tables
  • Supplemental files (if applicable; supplied in Word, not as a PDF)

Note: The keywords are search terms that will aid in the discoverability of the article in indexing services and search engines. They may or may not be different from the terms that you selected for the peer review process and areas of expertise. You will be asked to retype these search terms in the submission form when uploading your manuscript. These keywords will be included in the published article. If the search terms entered do not match the manuscript, the manuscript will serve as the default.

Manuscript Text

Maximum word count for original articles should not exceed 3,000 words.  In general, the text should be organized under the headings: Introduction, Materials and Methods, Results, Discussion, and Conclusions. The Results and Discussion must be separate sections.

Abbreviations

Rules for abbreviations and nomenclature follow those detailed annually in the first annual issue of J Biol Chem  

absorbance

A

acetate                    

OAc

acetyl                

Ac

5-bromodeoxyuridine       

BrdUrd

O-carboxymethylcellulose      

CM-cellulose

coenzyme A            

CoA

complementary DNA    

cDNA

counts per minute     

cpm

deoxy (carbohydrates and nucleotides)

d

deoxyribonuclease 

DNase

diethylaminoethylcellulose 

DEAE-cellulose

immunoglobulin

Ig (IgG, IgM, etc.)

inosine     

I, Ino

isotopes   

14C, 3H, 32P

nicotinamide-adenine dinucleotide    

 

nicotinamide-adenine dinucleotide phosphate

NADP+, NADPH

nicotinamide mononucleotide

NMN

optical density

OD

phosphate (in compounds)

P or P

phosphate (inorganic)

P1

poly(adenylic acid)

poly(A)

polyadenylated RNA 

poly(A)+RNA

ribonuclease

RNase

ribosomal ribonucleic acid

rRNA

sodium dodecyl sulfate


NaDodSO4

 

References  

All references must be cited within the text using the name and date format. For EndnoteTM users, the style is: http://endnote.com/downloads/style/dna-and-cell-biology

Example: The cell–cell adhesion structures are often found abnormal in various cancers (Vasioukhin, 2012).

If more than two authors are involved, use et al. (no italics) after the first author's name, e.g. (Rhee et al., 2018). If several works by the same authors are cited in one year, use a lowercase letter designation to indicate the individual citations [e.g. (Zhao et al., 2015a, 2015b)]. Use the same designation in the reference list.

Include the reference section as part of the main text file, not as a separate file. All references in the reference section must be double spaced and listed in alphabetical order at the end of the article. List all authors when there are six or fewer. When there are more than six authors, list the first six followed by et al. References must include complete titles and the complete page range of cited articles. Use journal abbreviations as provided by PubMed/Medline. If references to personal communications or unpublished data are used, they are not to be in the list of references. They should be referred to in the text in parentheses: (AB Jones, personal communication, year). Include among the references any articles that have been accepted but have not yet published; identify the name of the publication and add "In Press." If the reference has been published online, provide the DOI number in place of the page range.

Sample style for references:

    Journal article:

Chen J, Guan L, Tang L, Liu S, Zhou Y, Chen C, et al. T helper 9 cells: A new player in immune-related diseases. DNA Cell Biol 2019;38:1040-1047.  

    Book:

Futuyma DJ, Kirkpatrick M. Evolution, Fourth Edition. Sinauer Associates, Inc., Sunderland, MA, 2017.

    Chapter in a book:

Lemon KP, Earl AM, Vlamakis HC, Aguilar C, Kolter R. Biofilm development with an emphasis on Bacillus subtilis. In Bacterial Biofilms, T. Romero, ed. Springer, Heidelberg, 2008, Chapter 1, pp. 1–16.

    Proceedings:

Lavilla S, González-López JJ, Larrosa MN, Bartolomé RM, Prat G. Prevalence of the quinolone-modifying enzyme aac(6´)-Ib-cr in extended-spectrum b-lactamase-producing enterobacterial isolates in Barcelona. Abstract no. P1523, presented at the 18th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Barcelona, Spain, April 19–22, 2008.

    Abstract:

Scacheri PC, Crabtree JS, Kennedy AL, Swain GP, Ward JM, Marx SJ, et al. P2006. V804M RET mutation in MEN2A: first report. J Intern Med 2004;255:712 (abstract).

    Website:

Los Alamos National Laboratory Research Library. Databases: Bioinformatics. Available at https://library.lanl.gov/edb/BIOINF.htm Last accessed May 21, 2020.

Figure Legends

Figure legends should be uploaded as a separate Word file and double spaced. In the legend, provide explanations for any abbreviations, arrows, etc. that appear in the figure. If the illustration is taken from a copyrighted publication, permission must be secured, appropriate credit must be given in the legend, and a corresponding reference must appear in the reference section.

Tables

All tables should be prepared in one single Word file. Provide a title for each table. Cite tables in sequence in the text. Explain abbreviations used in the body of the table in footnotes. If the table is taken from a copyrighted publication, permission must be secured, appropriate credit must be given in the legend, and a corresponding reference must appear in the reference section.  

Figures

  • Submission of high resolution .TIFF or .EPS figure files is strongly recommended.
  • Figures should not be embedded within the manuscript file.
  • Cite figures consecutively in text within parentheses.
  • A legend should be supplied for each figure and all legends numbered consecutively.
  • Images should not show the name of a patient or a manufacturer.  
  • Do not include any illustrations as part of your text file.

Outstanding color photographs may be chosen for use on the cover, and authors are encouraged to consider this potential when submitting their manuscripts.   

Availability of Data Supporting Tables and Figures in Manuscripts

The Editors of DNA and Cell Biology are requiring the accessibility and transparency of data underlying the results of studies published in this journal. These data should be provided as a supplement(s).

Examples of the types and formats of data follow:

  • Uncropped scans of membranes used for Western blot images, autoradiograms, Southern blots
  • Confocal microscopy stack data files
  • In genome wide association studies (GWAS) all of the findings of unchanged and changed levels of gene expression of all data points acquired for the analysis
  • In clinical trials, links must be included for all data on each subject (encoded to meet HIPAA standards) whether deposited on ClinicalTrials.gov or other sites such as university or consortium servers (e.g., http://yoda.yale.edu/).  If data have not been previously deposited, then the data link at the investigator’s site is acceptable. The NCT number associated with the trial must be included.
  • Accession Number must be provided for each genetic sequence.
  • Digital images of all group members analyzed when a figure is prepared with selected data

Supplemental files: Additional figures, tables, and supporting materials, as appropriate should be included in submissions.

Correspondence Address

Following the references, provide the name and complete affiliation and institutional email address of the person to whom correspondence should be sent.

Manuscript Revisions

To upload a revision of a manuscript, the submitting author should log in to their Author Center and click on “Revised Manuscripts in Draft.”  All revised submissions will be required to meet all formatting conditions described herein.  Submissions that do not satisfy these requirements will be un-submitted and returned to the submitting author for proper configuration.

Journal Policies on: 

Licensing Information: OPEN ACCESS and Copyright
Data Sharing and Preprint Policies
Post-Acceptance and Post-Publication Policies
Correction Statements / Retractions
Reprints, Permissions, & Social Media Use
Plagiarism Detection Software
Definitions of Scientific Misconduct
Responding to Allegations of Scientific Misconduct
Press Embargo Policy
Publication Costs
Archiving and Preservation
Publisher Information

For questions regarding manuscript submissions, contact our Author Services Division

Our dynamic Author Benefits Program provides you with end-to-end benefits that ensure your hard work pays off and your published manuscript gets the attention it deserves not just upon publication, but permanently.

Liebert Open Access

Ensure maximum visibility, discoverability, and impact for your article with our Liebert Open Access (OA) option

Explore Liebert Open Access

Does your research funder have an open access mandate or would you like to expand the dissemination of your research?

The Liebert Open Access option enables authors to publish open access in our esteemed subscription-based journals.

The benefits of Liebert Open Access include:

  • High visibility; open access articles are freely available online upon publication
  • You retain copyright with the open access license allowing broad dissemination of your research
  • You can freely share your article in repositories and research networks without restrictions
  • Easy compliance with open access mandates
  • Rigorous editorial and peer-review
  • Targeted email announcement featuring a direct link to article

Identification and Marketing

Open access articles are listed with an OA icon in journal tables of content (TOC), TOC alerts, and in marketing announcements. Open access articles are highlighted and promoted in targeted email announcements to thousands of research leaders in your field.

Copyright and Licensing

If you choose to publish with open access, you will retain copyright of your article and a Creative Commons license will be applied. The liberal Creative Commons Attribution 4.0 (CC-BY) license is the default open access license used at Mary Ann Liebert, Inc., publishers. The CC-BY license permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.

At this time we allow authors to choose between the CC-BY or CC-BY-NonCommercial license. A limited number of journals offer NonCommercial licenses exclusively.

Ordering Open Access

Once your article has been accepted for publication in a journal, you will receive an email with information on ordering Liebert Open Access. If you would like more information about Liebert Open Access or would like to order open access, please email openaccess@liebertpub.com.

Publishing open access includes an article publication charge (APC) and authors are asked to fill out a short open access order form.  You can pay by credit card or receive an invoice to be returned with payment or via bank transfer. Please remember that traditional subscription journals can carry mandatory or optional author fees. The Liebert Open Access APC does not cover or replace existing publication or author fees.

Publishing biomedical or biotechnology research?

Biomedical researchers should consider publishing in BioResearch Open Access, a fully open access peer-reviewed journal dedicated to publishing top research in the biomedical and biotechnology fields. For details, please visit the information for authors on the journal website.

 *Please note that PubMedCentral, not the Publisher, has sole control over when the paper is made live on PMC.

 

Browse journals in the Liebert Open Access portfolio:

NIH Public Access Policy: In order to assist our authors who have NIH funding to comply with this policy, Mary Ann Liebert, Inc. publishers will deposit the final accepted paper (after copy-editing and proofreading) to PubMed Central (PMC) on behalf of the authors. Authors need not take any action. The manuscript's public access posting on PMC will occur 12 months after final publication. This service is provided free of charge. Please note that authors may not deposit manuscripts directly to PMC or other sites without permission from Mary Ann Liebert, Inc.

Publishing in Subscription Journals

By signing the copyright transfer statement, authors still retain a set of rights that allow for self-archiving.

Authors may archive their preprint manuscripts (version prior to peer review) at any time without restrictions. Authors may archive their postprint manuscripts (accepted version after peer review) in institutional repositories, preprint servers, and research networks after a 12 month embargo. The 12 month embargo period begins when the article is published online. Postprints must not be used for commercial purposes and acknowledgement must be given to the final publication, and publisher, by inserting the DOI number of the article in the following sentence: “Final publication is available from Mary Ann Liebert, Inc., publishers http://dx.doi.org/[insert DOI]”. Authors may archive on their personal website without an embargo provided their manuscript is updated with an acknowledgement to the publisher copyright and final published version.

The final published article (version of record) can never be archived in a repository, preprint server, or research network.

 

Publishing Open Access

Authors that wish to easily comply with funder or institutional open access mandates should consider publishing open access. Liebert Open Access option allows authors to make their research freely available online without restrictions. Additionally, Liebert Open Access option allows authors to retain copyright, archive and share the final published version of their article without restrictions. To publish open access please email openaccess@liebertpub.com or visit Liebert Open Access for more information.

The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.

Upcoming Events

Dec 05 - Dec 09, 2020